Within the SCC7 subcutaneous transplant tumor model, the combination treatment group displayed a substantial increase in the proportion of CD3+ T cells when compared with the other groups (Fig. 2H), with no significant differences detected in the proportions of CD4+ and CD8+ T cells among the groups (Fig. 2I). The gene discussed is CD8A; the disease is neoplasm.